Xlife Sciences AG (XLS) | WebDisclosure

PRESS RELEASE

published on 11/28/2025 at 13:10, 5 months 23 days ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 7 months 5 days ago

Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable

Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF

published on 10/16/2025 at 07:05, 7 months 5 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 7 months 5 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF

published on 09/23/2025 at 07:05, 7 months 28 days ago

Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025

Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF

published on 09/23/2025 at 07:05, 7 months 28 days ago

Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025

Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE

published on 09/23/2025 at 07:00, 7 months 28 days ago

Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025

Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF

published on 07/17/2025 at 07:05, 10 months 4 days ago

VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4

Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF

published on 07/17/2025 at 07:05, 10 months 4 days ago

VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing

Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE

published on 07/17/2025 at 07:00, 10 months 4 days ago

Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey

Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4

Published on 05/22/2026 at 00:45, 2 hours 11 minutes ago

Credissential Announces Private Placement
Published on 05/21/2026 at 23:00, 3 hours 56 minutes ago

Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 3 hours 56 minutes ago

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 3 hours 56 minutes ago

Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 4 hours 41 minutes ago

Linear Announces Acquisition, Share Consolidation and Private Placement

View all ACCESSWIRE

Published on 05/22/2026 at 02:40, 16 minutes ago

ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 21:45, 5 hours 11 minutes ago

Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 6 hours 46 minutes ago

Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 6 hours 50 minutes ago

EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 20:00, 6 hours 56 minutes ago

VINFAST INTRODUCES THE NEW-GENERATION VF 8, FEATURING COMPREHENSIVE ENHANCEMENTS

View all EQS

Published on 05/21/2026 at 17:50, 9 hours 6 minutes ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 9 hours 11 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 9 hours 11 minutes ago

CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 17:45, 9 hours 11 minutes ago

CDA - Résultats de 1er semestre 2025 2026
Published on 05/21/2026 at 16:35, 10 hours 21 minutes ago

260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026

View all LES ECHOS COMFI WIRE

News